Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Afya (AFYA) EBITDA (2018 - 2025)

Historic EBITDA for Afya (AFYA) over the last 8 years, with Q3 2025 value amounting to $29.3 million.

  • Afya's EBITDA rose 3074.8% to $29.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.9 million, marking a year-over-year increase of 1253.8%. This contributed to the annual value of $111.7 million for FY2024, which is 3634.98% up from last year.
  • According to the latest figures from Q3 2025, Afya's EBITDA is $29.3 million, which was up 3074.8% from $31.2 million recorded in Q2 2025.
  • Afya's 5-year EBITDA high stood at $43.9 million for Q1 2025, and its period low was $4.1 million during Q2 2021.
  • For the 5-year period, Afya's EBITDA averaged around $22.6 million, with its median value being $21.6 million (2022).
  • In the last 5 years, Afya's EBITDA plummeted by 6539.19% in 2021 and then surged by 42359.58% in 2022.
  • Quarter analysis of 5 years shows Afya's EBITDA stood at $8.8 million in 2021, then skyrocketed by 54.34% to $13.6 million in 2022, then skyrocketed by 51.78% to $20.6 million in 2023, then increased by 28.99% to $26.5 million in 2024, then rose by 10.26% to $29.3 million in 2025.
  • Its EBITDA stands at $29.3 million for Q3 2025, versus $31.2 million for Q2 2025 and $43.9 million for Q1 2025.